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1. Introduction 
 The technique High Performance Liquid Chromatography (HPLC) is so called because of its improved 
performance over the classical column chromatography. The technique basically involves the use of porous material as a  
stationary phase and the liquid mobile phase is pumped into the column under high pressure. The development of this 
technique is attributed to the small particle size of stationary phase. As the particle size is small the resistance to the flow of 
mobile phase is very high that is the reason why the high pressure is recommended.1, 18 Analytical method development and 
validation are key elements of any pharmaceutical development program. HPLC analysis method is developed to identify, 
quantity or purifying compounds of interest. This technical brief will focus on development and validation activities as 
applied to drug products. Method validation is the process of proving that an analytical method is acceptable for its intended 
purpose. The parameters for method validation as defined by ICH (International Conference on Harmonization) guidelines 
are Accuracy, Precision, Specificity, Limit of Detection, Limit of Quantitation, Linearity, Range, Robustness and 
Ruggedness2. From the literature review7-16 it has been found that only three analytical methods for the above combination 
have been reported. Therefore the attempt is made to develop simple, accurate, precise rapid and economical RP-HPLC 
method for determination of Atenolol (ATN) and Chlorthalidone (CTN) in combine dosage form. Atenolol [Figure 1] Chemically is 
RS)-2-{4-[2-Hydroxy-3-(propan-2 ylamino)propoxy]phenyl}acetamide. It is white to almost white powder used as anti- hypertensive having 
solubility in methanol and water, sparingly soluble in ethanol. While chlorthalidone [Figure 2] chemically is (RS)-2-chloro-
5-(3-Hydroxy-1-oxoisoindolin-3-yl) benzenesulphonamide.5, 6, 19, 20 It is white to yellowish white crystalline and practically 
odorless. Used as anti-hypertensive having solubility in methanol and insoluble in water, slightly soluble in ethanol.  
 
Figure 1 Chemical Structure of Atenolol 
 
Abstract 
 A RP-HPLC method for the estimation of  ATN (Atenolol) and CTN 
(chlorthalidone) in combined dosage form was developed  using Comosil RP-C18 (4.6 
x 250mm, 5µm) in an gradient mode with mobile phase comprising  of Methanol: 
Water (pH 3 using OPA) The flow rate was 1 mL/ min and effluent was monitored at 
226.0 nm. The retention times were found to be 2.2 min for ATN and 3.36 min for 
CTN. The assay exhibited a linear dynamic range of 40- 200 µg/mL for ATN and 10- 
50 µg/mL for CTN. The calibration curves were linear (r2 = 0.999 for ATN and r2 = 
0.999 for CTN) over the entire linear range. Mean % recovery was found to be 99.78 % 
for ATN and 99.30 % for CTN with % RSD was NMT 2 for both estimations which 
fully agrees with system suitability which is in good agreement with labeled amount of 
formulation. The % RSD for Intra- Day & Inter-Day Precision was NMT than 2 for 
both the drugs. The developed method was validated as per ICH guidelines 
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Figure 2 Chemical Structure of Chlorthalidone 
 
2. Experimentals 
2.1 Reagents & Chemicals 
Standard samples of ATN & CTN were received as gift samples from the leben laboratories akola (Maharashtra) 
and IPCA Laboratories mumbai (Maharashtra). The marketed formulation Tenoric (IPCA Laboratories) was purchased from 
the local market containing ATN 50 mg and CTN 12.5 mg and all the chemicals used were are of analytical grade. 
2.2 Instruments 
HPLC System of Younglin Quaternary pump with UV- VIS detector (190-990 nm) Software – Autochro. Analytical 
balance of citizen model CY 104 (microanalytical balance) was used for weighing purpose also the ultrasonicator servewell 
instruments model RC-SYSTEM MU-1700 used for sonication purpose. 
2.3 Preparation of Standard Solutions 
Standard Stock Solution (A) Accurately weighed  quantity of ATN (40.0 mg) was transferred to 10.0 mL volumetric flask 
and dissolved in methanol. The volume was made up to mark with methanol to get final concentration of 4000 µg/mL. The 
resultant solution was then sonicated for 10.0 min in ultrasonicator. 
Standard Stock Solution (B) Accurately weighed quantity of CTN (10.0 mg) was transferred to 10.0 mL volumetric flask 
and dissolved in methanol. The volume was made up to mark with methanol to get final concentration of 1000 µg/mL. The 
resultant solution was then sonicated for 10.0 min in ultrasonicator. 
Working Standard Solution (C) 0.1 mL of solution (A) and 0.1 mL of solution (B) was transferred to 10.0 mL volumetric 
flask and then the volume was made up to the mark with mobile phase to get final concentration of (40.0 µg/mL of ATN & 
10.0 µg/mL of CTN) respectively. The resultant solution was then sonicated for 10.0 min in ultrasonicator. 
2.4 Optimization of Mobile Phase and Chromatographic Conditions 
Procedure: The chromatographic conditions were set as per the optimized parameters. The mobile phase was allowed to 
equilibrate with stationary phase as was indicated by a steady baseline. Solution (C) was injected in the Rheodyne injector 
(20.0 µl) and the respective chromatograms were recorded. Various mobile phases were tried by permutations and 
combinations and also by varying column, flow rate, column temperature and type of buffers with varying pH and solvents. 
The various mobile phases tried are as follows. 
 Trial 1 Methanol: Water (80: 20) pH 7 
 Trial 2 Methanol: Water (60: 40) pH 7 
 Trial 3 Methanol: Water (50:50) pH 7 
 Trial 4 Methanol: Water (35: 65) pH 7 
 Trial 5 Acetonitrile: Methanol: Water (15: 30: 55) pH 7 
 Trial 6 Methanol: Water (60: 40) pH 3 
Above mentioned various mobile phases were tried. The mobile phase containing Methanol: water (60: 40) at pH 3, 
injection volume-20.0 µL flow rate of 1mL/min was selected, due to its high resolving power, sensitivity and suitability, for 
the determination of ATN and CTN. The chromatogram is shown in Figure 1. Hence the following optimized 
chromatographic parameters were selected to carry out further experimentation. 
 Column                            : Comosil RP-C18 (4.6 x 250mm, 5µm) 
 Flow Rate                        : 1 mL/min 
 Wavelength                     : 226.0 nm 
 Injection Volume            : 20.0 µL 
 Column Temperature    : Ambient 
 Run Time                        : 20.0 min 
 Mobile Phase                  : Methanol: Water (60:40) 
 pH                                    : 3 (Using OPA) 
2.5 System Suitability Studies 
System suitability is a pharmacopoeial requirement and is used to verify, whether the resolution and reproducibility 
of the chromatographic system are adequate for analysis to be carried out. It is performed to ensure that the system is 
operating properly and read to deliver results with acceptable accuracy and precision. The tests were performed by collecting 
data from five replicate injections of standard solutions. 
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Procedure: The chromatographic conditions were set as per the optimized parameters and mobile phase was allowed to 
equilibrate with stationary phase as was indicated by the steady baseline. Five replicate injections of mixed working 
standard solution (C) were injected in to the system, the chromatograms were recorded for both the drugs and the results are 
shown in Table 1 & 2. 
2.6 Analysis of Standard Laboratory Mixtures 
Preparation of Standard Laboratory Mixtures (Standard) 
ATN Standard Stock Solution (A) Accurately weighed quantity of ATN (40.0 mg) was transferred to 10.0 mL volumetric 
flask and dissolved in methanol. The volume was made up to mark with methanol to get final concentration of (4000 µg/mL 
of ATN). The resultant solution was then sonicated for 10.0 min in ultrasonicator.  
CTN Standard Stock Solution (B) Accurately weighed quantity of CTN (10.0 mg) was transferred to 10.0 mL volumetric 
flask and dissolved in methanol. The volume was made up to mark with methanol to get final concentration of (1000 µg/mL 
of CTN). The resultant solution was then sonicated for 10.0 min in ultrasonicator. 
Mixed Standard Solutions 0.1 mL of solution (A) and 0.1 mL of solution (B) was then transferred to 10.0 mL volumetric 
flask and volume was made up to the mark with mobile phase to get final concentration of (40.0 µg/mL of ATN & 10.0 
µg/mL of CTN) respectively. Similarly 0.2 mL of solution (A) and 0.2 mL of solution (B) was then transferred to 10.0 mL 
volumetric flask and volume was made up to the mark with mobile phase to get final concentration of (80.0 µg/mL of ATN 
& 20.0 µg/mL of CTN) respectively. The resultant solutions were then sonicated for 10.0 min in ultrasonicator. 
Preparation of Standard Laboratory Mixtures (Sample) 
Accurately weighed 50.0 mg of ATN and 12.5 mg of CTN (as per labeled requirement of marketed formulation) was 
transferred to 50.0 mL volumetric flask and dissolved in sufficient quantity of methanol. Then the volume was made up to 
the mark with methanol. The resultant solution was then sonicated in ultrasonicator for 10.0 min. then aliquot portions of 
0.4 mL and 0.8 mL was then transferred to two separate 10.0 mL volumetric flask and then volume was made up to the 
mark with mobile phase to get final concentrations of (40.0 µg/mL & 80.0 µg/mL of ATN and 10.0 µg/mL & 20.0 µg/mL of 
CTN) respectively. The peak area of standard laboratory mixture and sample laboratory mixture was compared to obtain the 
concentration. The amount of each drug estimated in laboratory mixture was calculated using following formula –  
                                                                At           Ds          Ws 
                             %  Estimation   =               x              x            x 100    
                                                                As           Dt          Wt 
   Where, 
                      At   =         Area count for sample solution 
As =        Area count for standard solution 
Ds =        Dilution factor for standard  
Dt =        Dilution factor for sample 
Ws =       Weight of standard (mg) 
Wt =        Weight of sample (mg) 
The results are shown in Table 3. 
2.7 Analysis of Marketed Formulation 
Preparation of Standard Solutions  
Prepared as per the methodology adopted for laboratory mixtures 
Preparation of Sample Solutions 
Ten Tablets were weighed accurately and ground to fine powder. An accurately weighed quantity of Tablet powder 
equivalent to (50 mg of ATN & 12.5 mg of CTN) were transferred to 50.0 mL of volumetric flask and dissolved in sufficient 
amount of methanol. Then the volume was made up to the mark with methanol. The resultant solution was then filtered 
through whatman filter paper (no. 41). The filtered solution was then sonicated in ultrasonicator for 10.0 min. aliquot 
portions of 0.8 mL was then transferred to the three separate 10.0 mL volumetric flask and then the volume was mad up to 
the mark with mobile phase to get final concentration of (80.0 µg/mL of ATN and 20.0 µg/mL of CTN) respectively.  
Procedure: Equal volume (20.0 L) of standard and sample solution was injected separately after equilibrium of stationary 
phase. The chromatograms were recorded and the response i.e. peak area of major peaks were measured. The amount of 
drug in a Tablet was calculated using following formula 
AT1 x WS1 x Ds x P1 
mg/Tablet =    ------------------------------- x Avg. wt 
AS1 x WT x Dt 
Where,  
AT1         = Average area of ATN/CTN peaks in Test chromatogram 
AS1         = Average area of ATN/CTN peaks in Standard chromatogram 
Ds           = Dilution factor for standard 
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Dt           = Dilution factor for test 
P1           = Potency of working standards of ATN/CTN of % w/w basis  
Avg. wt  = Average weight of 10 Tablets 
Further calculate the amount of ATN/CTN present in % of Label claim using following formula 
                                 Assay (mg/Tablet) x 100 
% Label Claim =   ------------------------------------ 
                                Label claim of ATN/CTN 
 
The results are shown in Table 4, while chromatogram is shown in Figure 4. 
2.8 Method Validation  
1. Linearity 
Preparation of Standard Solutions 
ATN Standard Stock Solution (A) Accurately weighed quantity of ATN (40.0 mg) was transferred to 10.0 mL volumetric 
flask and dissolved in methanol. The volume was made up to mark with methanol to get final concentration of (4000 µg/mL 
of ATN). The resultant solution was then sonicated for 10.0 min in ultrasonicator.  
CTN Standard Stock Solution (B) Accurately weighed quantity of CTN (10.0 mg) was transferred to 10.0 mL volumetric 
flask and dissolved in methanol. The volume was made up to mark with methanol to get final concentration of (1000 µg/mL 
of CTN). The resultant solution was then sonicated for 10.0 min in ultrasonicator. 
Mixed Standard Solutions aliquots portions of 0.1 to 0.5 mL from the standard stock solutions (A & B) were transferred to 
five 10.0 mL volumetric flasks and then volume was made up to the mark with mobile phase to get 5 different mixed 
standard solutions having concentrations of (40.0:10.0, 80.0:20.0, 120.0:30.0, 160.0:40.0, 200.0:50.0 µg/mL of ATN & 
CTN) respectively. The resultant solutions was then sonicated in ultrasonicator for 10.0 min  
Procedure Equal volumes (20.0 L) of 5 mixed standard solutions were injected separately after equilibrium of stationary 
phase. The chromatograms were recorded and the response i.e. peak area of major peaks were measured. Then calibration 
curve (Peak area vs concentration) was plotted and it is shown in Figure 5 & 6. The observations are shown in Table 5. 
2. Accuracy 
Preparation of Standard Solutions Standard solutions of (ATN & CTN) were prepared at the level of 80 %, 10.00 %, 120 
%.  
Preparation of Sample Solution To the preanalysed sample solution (80 µg/mL of ATN & 20 µg/mL of CTN) a known 
amount of standard solutions of pure drugs (ATN & CTN) were added in different levels i.e. 80%, 10.00 %, 120%. The 
results of recovery studies shown in Table 6. The percent recovery was then calculated by using formula; 
                                                                Ew - B 
                                     % Recovery =   ----------   X 100 
                               C 
Where,  
             Ew = Total drug estimated (mg) 
             B= Amount of drug contributed by pre analyzed Tablet powder (mg)                                        
             C= Weight of pure drug added (mg) 
3. Precision  
3.1 Intra-Day Precision  
It was determined by analyzing the 3 different solutions having concentration (80.0 µg/mL of ATN & 20.0 µg/mL of CTN) 
at 3 different times over a period of day. 
3.2 Inter-Day Precision 
It was determined by analyzing the 3 different solutions having concentration (80.0 µg/mL of ATN & 20.0 µg/mL of CTN) 
at 3 days over a period of week. 
Procedure Equal volumes (20.0 L) of these solutions were injected separately after equilibrium of stationary phase. The 
chromatograms were recorded and the response i.e. peak areas, retention time of major peaks were measured. The results 
are shown in Table 7 & 8. 
4. Specificity 
Specificity is an ability to measures accurately and specifically the analyte of interest in the other components that may be 
expected to be present in the sample matrix. 
Preparation of Standard Solutions The standard solutions were prepared as per the methodology adopted for laboratory 
mixtures. 
Preparation of Sample Solution: Sample solution of marketed formulation was prepared as per the methodology adopted 
for marketed formulation analsis. 
Procedure: Equal volume (20.0 L) of standard and sample solution was injected separately after equilibrium of stationary 
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phase. The chromatograms were recorded and the response i.e. peak area, retention time of the major peaks were measured. 
Along with this the interference between the active ingredient and its excipients was also checked. The corresponding 
chromatograms are shown in Figure 12 & 13. 
5. Robustness  
Preparation of Sample Solution: Sample solution of marketed formulation was prepared as per the methodology adopted 
for marketed formulation analysis. 
Procedure: Equal volume (20.0 L) of sample solution was injected separately after equilibrium of stationary phase. Then 
deliberate variation in method parameters such as flow rate (<0.2mL/min), change in detection wavelength (<2 nm) was 
carried out. The chromatograms were recorded and the response i.e. peak area, retention time of the major peaks were 
measured. The results are shown in Table 9 chromatograms are shown in Figure 14 & 15. 
6. Ruggedness  
Ruggedness of the method was studied by two different analysts using same operational and environmental 
conditions. A sample solutions prepared as per the methodology adopted in section 5.2 having concentration (80.0 µg/mL of 
ATN & 20.0 µg/mL of CTN) respectively, were analyzed and concentrations were determined. The results are shown in 
Table 10. 
 
3. Results and Discussion 
Optimization of Mobile Phase and Chromatographic Conditions 
 
Figure 3 Optimized Chromatogram of ATN & CTN 
 
Observation 
Good resolution with minimized tailing also proper peak shape and system suitability was observed within the 
limits. Hence the above chromatographic parameters are finalized.  
System Suitability Studies 
Table 1 Result of System Suitability Studies for (ATN) 
System Suitability Test (ATN) 
Sr. No 
Area 
Reproducibility 
Retention Time 
Tailing 
Factor 
Resolution 
Theoretical 
Plates 
1 2840 2.3 1.71 0 3303 
2 2853 2.3 1.71 0 3303 
3 2856 2.31 1.71 0 3322 
4 2854 2.31 1.71 0 3322 
5 2860 2.31 1.72 0 3322 
Mean 2852.6 2.306 1.712 0 3314.4 
SD 7.536 0.0054 0.0044 0 10.40 
%RSD 0.264 0.237 0.261 0 0.313 
Limit NMT 2% NMT 1% < 2 > 2 > 2000 
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Observation 
All the parameters of system suitability are observed within the limits for ATN. 
Table 2 Results of System Suitability Studies for (CTN) 
System Suitability Test (CTN) 
Sr. No 
Area 
Reproducibility 
Retention Time 
Tailing 
Factor 
Resolution 
Theoretical 
plates 
1 1366 3.51 1.75 3.31 2460 
2 1376 3.51 1.75 3.31 2460 
3 1379 3.51 1.81 3.27 2460 
4 1363 3.51 1.75 3.31 2460 
5 1375 3.5 1.75 3.27 2698 
Mean 1371.8 3.508 1.762 3.294 2507.6 
SD 6.90 0.0044 0.0268 0.021 106.43 
%RSD 0.503 0.127 1.52 0.665 4.24 
Limit NMT 2% NMT 1% < 2 > 2 > 2000 
 
Observation  
All the parameters of system suitability are observed within the limits for CTN. 
Analysis of Standard Laboratory Mixtures 
Analysis of Standard Laboratory Mixture 
Sr. 
No 
Standard 
Amount 
Taken 
[µg/mL] 
Sample Amount 
Taken [µg/mL] 
Area of 
Standard 
Area of Sample 
% Amount 
Estimated 
 
ATN CTN ATN CTN ATN CTN ATN CTN ATN CTN 
1 40 10 40 10 2840 1366 2825 1361 99.47 99.63 
2 80 20 80 20 3840 1383 3827 1376 99.66 99.49 
 
Mean 3340 1374.5 3326 1368.5 99.56 99.56 
SD 707.1 12.02 708.5 10.6 0.134 0.099 
%RSD 21.17 0.874 21.3 0.775 0.1346 0.0995 
Table 3 Results of Analysis of Standard Laboratory Mixtures 
 
Analysis of Marketed Formulation 
Table 4 Results of Marketed Formulation Analysis 
Analysis of Marketed Formulation 
Sr. 
No 
Standard 
Amount 
Taken 
[µg/mL] 
Sample 
Amount Taken 
[µg/mL] 
Area of 
Standard 
Area of Sample 
Amount 
Found 
[µg/mL] 
% Amount 
Found 
 
ATN CTN ATN CTN ATN CTN ATN CTN ATN CTN ATN CTN 
1 
  
80 20 
  
3068 1510 79.9 19.9 99.875 99.5 
2 80 20 80 20 3102 1540 3080 1521 80.5 20.3 100.62 101 
3 
  
80 20 
  
3075 1517 80.2 20.1 100.25 100.5 
 
Mean 3074.3 1516 80.2 20.1 100.25 100.5 
SD 6.0 5.56 0.3 0.2 0.375 1 
%RSD 0.19 0.367 0.374 0.99 0.374 0.995 
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Figure 4 Chromatogram of Marketed Formulation 
The proposed method was applied to the determination of ATN & CTN in marketed formulation the mean % 
amount found was 100.25 (ATN) & 100.5 (CTN) with % RSD values is NMT 2.0% indicates the developed method was 
successfully applied for analysis of marketed formulation. All the results found are in good agreement with the label content 
of marketed formulation.  
Method Validation 
1. Linearity 
 
 
Figure 5 Calibration Curve of ATN 
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Figure 6 Calibration Curve of CTN 
Table 5 Linearity Studies of ATN & CTN 
Concentration (µg/mL) Peak Area 
ATN CTN ATN CTN 
40 10 1844 870 
80 20 3840 1838 
120 30 5640 2696 
160 40 7420 3585 
200 50 9356 4514 
 
Mean 5620 2700.6 
SD 2942.13 1428.79 
%RSD 52.35 52.90 
 
In both calibration curves the r2 value was found to be 0.999 which nearly equals to unity. The regression equation 
for ATN was y = 46.51x + 38.8 while for CTN it was y = 90.35x - 9.9. It indicates the capability of developed method to 
estimate both the drugs over the desired concentration range.  
 
Figure 7 Linearity Chromatogram for (40 µg/mL of ATN & 10 µg/mL of CTN) 
 
Figure 8 Linearity Chromatogram for (80 µg/mL of ATN & 20 µg/mL of CTN) 
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Figure 9 Linearity Chromatogram for (120 µg/mL of ATN & 30 µg/mL of CTN) 
 
Figure 10 Linearity Chromatogram for (160 µg/mL of ATN & 40 µg/mL of CTN) 
 
Figure 11 Linearity Chromatogram for (200 µg/mL of ATN & 50 µg/mL of CTN) 
 
2. Accuracy 
This is performed on the basis of recovery studies by standard addition method. Standard solutions of pure drugs (ATN & 
CTN) were added in different levels i.e. 80%, 100 %, 120%. 
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Table 6 Results of Recovery Studies 
 Recovery Studies 
Sr. 
No 
Pre-analysed 
Sample Solution 
[µg/mL] 
Excess Pure 
Drug Added 
[µg/mL] 
Amount 
Recovered  
[µg/mL] 
Area % Recovery 
 
ATN CTN ATN CTN ATN CTN ATN CTN ATN CTN 
1 80 20 64 16 63.8 15.8 6144 3231 99.68 98.75 
2 80 20 80 20 79.9 20 7680 4038 99.87 100 
3 80 20 96 24 95.8 23.8 9216 4845 99.79 99.16 
 
Mean 99.78 99.30 
SD (n=3) 0.093 0.636 
% RSD 
(n=3) 
0.094 0.640 
The mean % recovery with % RSD for ATN was found to be 99.78, 0.094 while for CTN it was 99.30, 0.640. 
The % RSD here does not exceed 2 which fully agrees with system suitability hence the developed RP-HPLC method was 
found to be sufficiently accurate. 
 
3. Precision 
3.1 Intra- Day Precision 
Table 7 Results of Intra- Day Precision Studies 
Sr. 
No 
Samples 
Amount Taken 
[µg/mL] 
Retention 
Time 
Area of Peaks 
Amount 
Found 
[µg/mL] 
% Amount 
Found 
  
ATN CTN ATN CTN ATN CTN ATN CTN ATN CTN 
1 
Precision 1 (Ist 
Time) 
80 20 2.3 3.5 3068 1510 79.9 19.9 99.8 99.5 
2 
Precision 2 (II 
ndTime) 
80 20 2.3 3.5 3072 1516 80.2 20.1 100.2 101 
3 
Precision 3 
(III rd Time) 
80 20 2.31 3.5 3076 1517 80.5 20.3 100.6 102 
 
Mean 2.30 3.5 3072 1514.3 80.2 20.1 100.2 101 
SD 0.005 0 4 3.78 0.3 0.2 0.375 1 
%RSD 0.25 0 0.13 0.25 0.37 0.99 0.37 1 
3.2 Inter- Day Precision 
Table 8 Results of Inter- Day Precision Studies 
Sr. 
No 
Samples 
Amount Taken 
[µg/mL] 
Retention 
Time 
Area of Peaks 
Amount 
Found 
[µg/mL] 
% Amount 
Found 
  
ATN CTN ATN CTN ATN CTN ATN CTN ATN CTN 
1 
Precision 
1(Day 1) 
80 20 2.3 3.51 3072 1510 80.2 19.9 100.25 99.5 
2 
Precision 
2(Day 2) 
80 20 2.31 3.5 3075 1508 80.35 19.8 100.43 99 
3 
Precision 
3(Day 3) 
80 20 2.3 3.51 3070 1512 80.3 20.2 100.37 101 
 
Mean 2.30 3.50 3072 1510 80.2 19.9 100.3 99.8 
SD 0.005 0.006 2.51 2 0.076 0.20 0.09 1.04 
%RSD 0.25 0.16 0.08 0.132 0.095 1.04 0.095 1.042 
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Precision was determined as Intra-day & Inter-day precision. Reproducibility in retention time and peak area is 
seen in both intra and inter day precision studies with a %RSD (NMT than 2%) for both retention time and peak area 
which is in agreement with system suitability. Therefore, the proposed HPLC method for the determination of ATN and 
CTN in a tablet was found to be sufficiently precise. 
4. Specificity 
 
Figure 12 Chromatogram of ATN & CTN Working Standards 
 
Figure 13 Chromatogram of Marketed Formulation (Specificity) 
In the chromatogram obtained with working standard and marketed formulation solution interference is not 
observed at the retention time of any peak. Therefore, the proposed HPLC method for the determination of ATN and CTN in 
a tablet was found to be specific. 
5. Robustness 
Table 9 Results of Robustness Studies 
Sr. 
No 
Samples Condition 
Amount Taken 
[µg/mL] 
Retention 
Time 
Area of 
Peaks 
% Amount 
Found 
   
ATN CTN ATN CTN ATN CTN ATN CTN 
1 Robustness 1 
Flow rate (<0.2 
mL/min) 
80 20 2.31 3.5 7179 3737 99.7 99.5 
2 Robustness 2 Wavelength(<2.0 nm) 80 20 2.34 3.54 7236 3746 100.2 100.5 
 
Mean 2.32 3.52 
7207.
5 
3741.
5 
100 100 
SD 0.02 0.02 40.3 6.36 0.35 0.70 
%RSD 0.91 0.80 0.5 0.17 0.35 0.70 
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Figure 14 Chromatogram of Robustness (<2.0 nm) 
 
Figure 15 Chromatogram of Robustness (<0.2mL/min) 
The results of assay of test solution were not affected by varying the conditions. They fully agree with the results obtained  
under original conditions. The % RSD for (Retention time, Peak area and % Amount Found) is not more than 2% for 
both (ATN & CTN) which is in agreement with system suitability. Hence the proposed HPLC method for the determination 
of ATN and CTN in a tablet was found to be robust. 
6. Ruggedness                        Table 10 Results of Ruggedness Studies 
 
% Amount Found 
Sr. 
No 
Amount Taken [µg/mL] Intra-Day Inter-Day Different Analyst 
 
ATN CTN ATN CTN ATN ATN ATN CTN 
1 80 20 99.88 99.5 100.25 99.5 99.8 100 
2 80 20 100.3 100.5 100.43 99 100.2 101 
3 80 20 100.6 101.5 100.37 101 100.0 100.5 
 
Mean 100.3 100.5 100.35 99.8 100 100.5 
SD 0.375 1 0.09 1.04 0.265 0.70 
%RSD 0.374 0.9 0.095 1.042 0.56 0.72 
 
The mean % amount found for (ATN & CTN) by different analyst was found to be 100% (ATN) and 
100.5%(CTN) also the % RSD values for (Intra-Day, Inter-Day and Different analyst) studies for both the drugs is not 
more than 2% for both (ATN & CTN) which is agreement with system suitability hence the proposed HPLC method for the 
determination of ATN and CTN in a tablet was found to be rugged. 
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4. Conclusion 
The developed RP-HPLC method was found to be simple, accurate, sensitive, precise, specific, economical and 
rapid. The developed RP-HPLC method shows the good resolution between ATN and CTN within the run time of 20 min. 
The developed RP-HPLC method is very simple involving no complicated sample preparations. The developed RP-HPLC 
method was found to be highly specific. The developed RP-HPLC method was found to be linear over wider concentration 
range. Therefore the developed RP-HPLC method can be applied for routine quantitative and qualitative analysis of ATN 
and CTN in bulk and pharmaceutical formulations like tablets. The developed RP-HPLC method was validated as per the 
ICH guidelines.  
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